Determination of Endogenous Neurotoxin 1-Acetyl-6,7-Dihydroxyl-1,2,3,4-Tetrahydroisoquinoline in Rat Substantia Nigra by High Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry

Analytical Letters

Volumn 46, Issue 18, 2013, Pages 2828-2834

  Xie, Bingjie ^a   Xiong, Yan ^a   Ullah, Kaleem ^a   Peng, Lei ^a   Lin, Fankai ^a   Zhang, Zhensong ^a   Qing, Hong ^a   Deng, Yulin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

1 Acetyl 6,7 dihydroxyl 1,2,3,4 tetrahydroisoquinoline; LC MS MS; Liquid chromatography; Mass spectrometry

Indexed keywords

EID: 84889013272     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032719.2013.814057     Document Type: Article

References (14)

1. Bennett, B. D., E. H. Kimball, M. Gao, R. Osterhout, S. J. Van Dien, and J. D. Rabinowitz. 2009. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat. Chem. Biol. 5: 593 - 599.
2. Cai, H. L., R. H. Zhu, and H. D. Li. 2010. Determination of dansylated monoamine and amino acid neurotransmitters and their metabolites in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Biochem. 396: 103 - 111.
3. Davis, G. C., A. C. Williams, S. P. Markey, M. H. Ebert, E. D. Caine, C. M. Reichert, and I. J. Kopin. 1979. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1: 249 - 254.
4. Deng, Y., Y. Zhang, Y. Li, S. Xiao, D. Song, H. Qing, Q. Li, and A. H. Rajput. 2012. Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains. J. Neural. Transm. 119: 435 - 441.
5. Driver, J. A., A. Smith, J. E. Buring, J. M. Gaziano, T. Kurth, and G. Logroscino. 2008. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 31: 2003 - 2005.
6. Haber, H., N. Stender, A. Mangholz, H. Ehrenreich, and M. F. Melzig. 1999. Quantitative determination of endogenous tetrahydroisoquinoline salsolinol in peripheral blood mononuclear cells by gas chromatography-mass spectrometry. J. Chromatogr. B 735: 299 - 303.
7. Hu, G., P. Jousilahti, S. Bidel, R. Antikainen, and J. Tuomilehto. 2007. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30: 842 - 847.
8. Langston, J. W., P. Ballard, J. W. Tetrud, and I. Irwin. 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979 - 980.
9. Luo, B., K. Groenke, R. Takors, C. Wandrey, and M. Oldiges. 2007. Simultaneous determination of multiple intracellular metabolites in glycolysis, pentose phosphate pathway and tricarboxylic acid cycle by liquid chromatography-mass spectrometry. J. Chromatogr. A 1147: 153 - 164.
10. Rajput, A. H. 2001. Environmental toxins accelerate Parkinson's disease onset. Neurology 56: 4 - 5.
11. Rojkovicova, T., Y. Mechref, J. A. Starkey, G. Wu, R. L. Bell, W. J. McBride, and M. V. Novotny. 2008. Quantitative chiral analysis of salsolinol in different brain regions of rats genetically predisposed to alcoholism. J. Chromatogr. B 863: 206 - 214.
12. Wang, R., H. Qing, X. Q. Liu, X. L. Zheng, and Y. L. Deng. 2008. Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. Neurosci. Bull. 24: 125 - 132.
13. Wu, H., B. Yuan, and Y. M. Liu. 2011. Chiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: Observation of complex stereoisomerism. J. Chromatogr. A 1218: 3118 - 3123.
14. Zhang, Y., Y. Li, and Y. L. Deng. 2012. Determination of endogenous salsolinol and N-methylsalsolinol in rat brain by LC-ESI-QQQ. Anal. Methods 4: 2027 - 2032.